CVS expands flu and COVID-19 testing and treatment services at 1,600 locations

From Nasdaq: 2025-02-27 12:51:50

CVS Health Corp expands flu and COVID-19 testing and treatment at 1,600 locations across 37 states. Patients can now get a 3-in-1 combo test for Influenza A, Influenza B, and COVID-19 with one swab. In some states, pharmacists offer testing and antiviral treatment in one appointment. Tests cost $29.99, assessments are $45. CVS also provides at-home test kits and prescription delivery. CVS stock is trading at $64.72, up 1.35%. Flu and COVID-19 vaccines are available at CVS Pharmacy and MinuteClinic locations nationwide.



Read more at Nasdaq: CVS Expands Flu And COVID-19 Testing And Treatment Services